PLAU and pancreatic ductal adenocarcinoma: The expression levels of uPA, uPAR, IGF-1, and IGFBP-3 mRNA were significantly greater in pancreatic ductal adenocarcinoma than in benign mucinous cystadenomas’ control tissues [31].